Pricing

Bellicum Pharmaceuticals Inc (BLCM)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard A. Fair
Employees:
7
3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098
(832) 384-1100
Stock Split History
DateRatio
2020-02-06 1:10
Bellicum Pharmaceuticals, Inc. focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the. treatment of solid tumors expressing the prostate stem cell antigen.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available